FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

38112003: un (valeur de l'attribut)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
615211000077111 un (valeur de l'attribut) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
771016011 One (qualifier value) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
un est un(e) (attribut) modificateur adjectival général false Inferred relationship Some
un est un(e) (attribut) nombre true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely fluvoxamine maleate 150 milligram/1 each prolonged-release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely fluvoxamine maleate 150 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 3
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Fluvoxamine maleate 100 mg prolonged-release oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Fluvoxamine maleate 100 mg prolonged-release oral capsule Count of base of active ingredient False un Inferred relationship Some
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 3
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 2
Product containing precisely fexofenadine hydrochloride 6 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely fexofenadine hydrochloride 6 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Acetaminophen 5 mg/mL and caffeine 650 microgram/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 2
Acetaminophen 5 mg/mL and caffeine 650 microgram/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
Tetracycline 10 mg/g cutaneous ointment Has concentration strength denominator value False un Inferred relationship Some 1
Tetracycline 10 mg/g cutaneous ointment Count of base of active ingredient False un Inferred relationship Some
Product containing precisely sulfacetamide sodium 300 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely sulfacetamide sodium 300 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely guanfacine (as guanfacine hydrochloride) 1 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely guanfacine (as guanfacine hydrochloride) 1 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely guanfacine (as guanfacine hydrochloride) 1 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 2
Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 3
Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution Has concentration strength numerator value (attribute) False un Inferred relationship Some 1
Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 2
Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely bromazine hydrochloride 2.5 milligram/1 milliliter and codeine phosphate 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
Product containing precisely bromazine hydrochloride 2.5 milligram/1 milliliter and codeine phosphate 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 3
Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Aluminum acetate 130 mg/mL ear solution Count of base of active ingredient False un Inferred relationship Some
Aluminum acetate 130 mg/mL ear solution Has concentration strength denominator value False un Inferred relationship Some 1
Estradiol 1.04 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False un Inferred relationship Some
Estradiol 1.04 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False un Inferred relationship Some 1
Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 3
Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 2
Tetracycline 10 mg/mL cutaneous lotion Has concentration strength denominator value False un Inferred relationship Some 1
Tetracycline 10 mg/mL cutaneous lotion Count of base of active ingredient False un Inferred relationship Some
Product containing precisely guanfacine (as guanfacine hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely guanfacine (as guanfacine hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 2
Proparacaine hydrochloride 5 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
Proparacaine hydrochloride 5 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
Product containing precisely cyproheptadine hydrochloride 400 microgram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely cyproheptadine hydrochloride 400 microgram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Prednisolone (as prednisolone sodium phosphate) 5 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
Prednisolone (as prednisolone sodium phosphate) 5 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
Rimantadine hydrochloride 10 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
Rimantadine hydrochloride 10 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 2
Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 3
Estradiol 1.56 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False un Inferred relationship Some 1
Estradiol 1.56 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False un Inferred relationship Some
Product containing precisely citalopram (as citalopram hydrobromide) 2 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely citalopram (as citalopram hydrobromide) 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely guanfacine (as guanfacine hydrochloride) 3 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely guanfacine (as guanfacine hydrochloride) 3 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Aluminum acetate 80 mg/mL ear solution Has concentration strength denominator value False un Inferred relationship Some 1
Aluminum acetate 80 mg/mL ear solution Count of base of active ingredient False un Inferred relationship Some
Product containing precisely ibuprofen 20 milligram/1 milliliter and pseudoephedrine hydrochloride 3 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely ibuprofen 20 milligram/1 milliliter and pseudoephedrine hydrochloride 3 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
Betamethasone 120 microgram/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
Betamethasone 120 microgram/mL oral solution Count of base of active ingredient False un Inferred relationship Some
Dyphylline 10.7 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
Dyphylline 10.7 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
Progesterone 100 mg vaginal tablet Has presentation strength denominator value False un Inferred relationship Some 1
Progesterone 100 mg vaginal tablet Count of base of active ingredient False un Inferred relationship Some
Terbutaline sulfate 200 microgram/mL solution for inhalation Count of base of active ingredient False un Inferred relationship Some
Terbutaline sulfate 200 microgram/mL solution for inhalation Has concentration strength denominator value False un Inferred relationship Some 1
Theophylline 5.33 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
Theophylline 5.33 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely prednisolone 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely prednisolone 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch Has concentration strength denominator value False un Inferred relationship Some 1
Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch Has concentration strength denominator value False un Inferred relationship Some 2
Olopatadine hydrochloride 665 microgram/actuation nasal spray Count of base of active ingredient False un Inferred relationship Some
Product containing precisely metronidazole 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely metronidazole 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 3
Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 2
Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely xylometazoline 500 microgram/1 milliliter conventional release nasal spray (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely xylometazoline 500 microgram/1 milliliter conventional release nasal spray (clinical drug) Count of base of active ingredient False un Inferred relationship Some

Start Previous Page 85 of 217 Next End


This concept is not in any reference sets

Back to Start